Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...

Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...

Preserving levels of brain glucose metabolism can both slow cognitive decline and reduces the risk of conversion to dementia.

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Johnson & Johnson said Monday it expects to accelerate sales growth beyond Wall Street expectations in the field of ...

We delivered strong revenue growth in 2024 and significantly advanced our industry leading neuroscience pipeline, including achievement of ...

Endometriosis, ovarian cysts, uterine fibroids and female orgasmic disorder are now on the list for medical conditions that ...

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Auvelity preliminary 4Q and full year 2024 net product sales of $92.6 million and $291.4 million, respectively Sunosi ...